Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome

被引:185
|
作者
Lay, JD
Tsao, CJ
Chen, JY
Kadin, ME
Su, IJ
机构
[1] NATL CHENG KUNG UNIV HOSP,DEPT PATHOL,TAINAN 704,TAIWAN
[2] NATL CHENG KUNG UNIV HOSP,DEPT INTERNAL MED,TAINAN 704,TAIWAN
[3] COLL MED,TAINAN 704,TAIWAN
[4] NATL TAIWAN UNIV,COLL MED,GRAD INST MICROBIOL,TAIPEI 100,TAIWAN
[5] NATL TAIWAN UNIV,COLL MED,GRAD INST PATHOL,TAIPEI 100,TAIWAN
[6] BETH ISRAEL DEACONNESS MED CTR,DEPT PATHOL,BOSTON,MA
[7] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 100卷 / 08期
关键词
tumor necrosis factor-alpha; Epstein-Barr virus; T/NK cell lymphoma; hemophagocytic syndrome;
D O I
10.1172/JCI119728
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A potentially fatal hemophagocytic syndrome has been noted in patients with malignant lymphomas, particularly in EBV-infected T cell lymphoma, Cytokines, such as interferon-gamma (IFN-gamma), TNF-alpha, and IL-1 alpha, are elevated in patients' sera. To verify whether infection of T cells by EBV will upregulate specific cytokine genes and subsequently activate macrophages leading to hemophagocytic syndrome, we studied the transcripts of TNF-alpha, IFN-gamma, and IL-1 alpha in EBV-infected and EBV-negative lymphoma tissues, By reverse transcription PCR analysis, transcripts of TNF-alpha were detected in 8 (57%) of 14 EBV-infected T cell lymphomas, higher than that detected in EBV-negative T cell lymphoma (one of six, 17%), EBV-positive B cell lymphoma (two of five, 40%) and EBV-negative B cell lymphomas (one of seven, 14%). Transcripts of IFN-gamma were consistently detected in T cell lymphoma and occasionally in B cell lymphoma, but were independent of EBV status. IL-1 alpha expression was not detectable in any category. Consistent with these in vivo observations, in vitro EBV infection of T cell lymphoma lines caused upregulation of TNF-alpha gene, and increased secretion of TNF-alpha, but not IFN-gamma or IL-1 alpha. Expression of TNF-alpha, IFN-gamma, and IL-1 alpha was not changed by EBV infection of B cell lymphoma lines. To identify the specific cytokine(s) responsible for macrophage activation, culture supernatants from EBV-infected T cells were cocultured with a monocytic cell line U937 for 24 h. Enhanced phagocytosis and secretion of TNF-alpha, IFN-gamma, and IL-1 alpha by U937 cells were observed, and could be inhibited to a large extent by anti-TNF-alpha (70%), less effectively by anti-IFN-gamma (31%), but almost completely by the combination of anti-TNF-alpha and anti-IFN-gamma (85%). Taken together, the in vivo and in vitro observations suggest that infection of T cells by EBV selectively upregulates the TNF-alpha expression which, in combination with IFN-gamma and probably other cytokines, can activate macrophages. This study not only highlights a probable pathogenesis for virus-associated hemophagocytic syndrome, but also suggests that anti-TNF-alpha will have therapeutic potential in the context of their fatal syndrome.
引用
收藏
页码:1969 / 1979
页数:11
相关论文
共 50 条
  • [1] Elevated Tumor Necrosis Factor-alpha Expression in Periapical Lesions Infected by Epstein-Barr Virus
    Hernadi, Katinka
    Gyoengyoesi, Eszter
    Meszaros, Beata
    Szakacs, Levente
    Szalmas, Anita
    Csoma, Eszter
    Mogyorosi, Richard
    Czompa, Levente
    Veress, Gyoergy
    Varga, Istvan
    Marton, Ildiko Judit
    Konya, Jozsef
    JOURNAL OF ENDODONTICS, 2013, 39 (04) : 456 - 460
  • [2] Sequential Quantification of Epstein-Barr Virus DNA in a Case of Epstein-Barr Virus—Associated Hemophagocytic Syndrome
    Toru Takahashi
    Eiichi Oeda
    Yutaka Sato
    Yukio Tanizawa
    International Journal of Hematology, 2002, 76 : 290 - 291
  • [3] Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome
    Yoshioka, M
    Kikuta, H
    Ishiguro, N
    Endo, R
    Kobayashi, K
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) : 410 - 419
  • [4] Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome
    Takahashi, T
    Oeda, E
    Sato, Y
    Tanizawa, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (03) : 290 - 291
  • [5] Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis
    Marsh, Rebecca A.
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [6] MONOCLONAL PROLIFERATION OF EPSTEIN-BARR VIRUS-INFECTED T-CELLS IN A PATIENT WITH VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    NOMA, T
    KOU, K
    YOSHIZAWA, I
    KAWANO, Y
    MIYASHITA, T
    MIZUTANI, S
    YATA, J
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (10) : 734 - 738
  • [7] Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas
    Finberg, RW
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (05) : 349 - 353
  • [8] Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection
    Endo, R
    Yoshioka, M
    Ebihara, T
    Ishiguro, N
    Kikuta, H
    Kobayashi, K
    MEDICAL HYPOTHESES, 2004, 63 (04) : 582 - 587
  • [9] FAILURE TO DETECT HETEROFIL ANTIGENS IN EPSTEIN-BARR VIRUS-INFECTED CELLS AND TO DEMONSTRATE INTERACTION OF HETEROFIL ANTIBODIES WITH EPSTEIN-BARR VIRUS
    HENLE, W
    HENLE, G
    HEWETSON, J
    ROCCHI, G
    LEIKOLA, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1974, 17 (02): : 281 - 286
  • [10] EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    KIKUTA, H
    LEUKEMIA & LYMPHOMA, 1995, 16 (5-6) : 425 - 429